The South China Post did a story today on China’s having used its antitrust law to block Coke’s purchase of Huiyuan. The article is entitled, “China raises chills as Coke bid bottled up,” and it talks about whether the blocking of this deal will signal the death of foreign private equity investments in China.
My view is that it absolutely positively will not. In fact, a private equity company contacted me today regarding its desire to purchase a relatively small Chinese niche food company. They asked whether I thought the Coke deal would have any impact on their purchase and I predicted it would not. I told them I thought the company it was seeking to buy was way too regionalized, way too small, and way too insignificant in China’s grand scheme of things for their to be any linkage at all with Coke’s failed deal.
The South China Post hints otherwise, but I attribute that to same-day overreaction:
The article makes the requisite mention of how “US private equity firm Carlyle Group” was unable to buy a controlling stake in tractor parts maker Xugong “after three years of bureaucratic hold-ups” after “Chinese media raised eyebrows abroad by claiming repeatedly that Xugong was a ‘strategic’ national business.” It then quotes Tang Hao of H&J Vanguard Consulting Group saying foreign investors had thought juice was “not a sector that involved economic or national security issues.”
CLB’s own Steve Dickinson is then extensively quoted:

Steve Dickinson, a partner at US law firm Harris Bricken who has advised foreign investors in China since 1979, said the deal provided false hopes Beijing was opening up to foreign buyers.
“After the decision, I think leveraged buyout funds that have set up in Hong Kong will go home,” he said.
International buyout funds with local offices include US giant Blackstone Group and Europe’s largest buyout house, Permira, as well as Carlyle. Blackstone posted a US$1.33 billion loss last year.
“It’s anyone’s guess whether those large funds will stay [in China] or, given the problems back home, just focus on the US and Europe,” said Simon Littlewood, the chief executive of venture capital firm London Asia Capital.
* * * *
Some foreign investors may treat the Coca-Cola setback as a one-off decision. “It may be that lawyers realise after analysing the decision that, in substance, there is a very meaningful market share Coke could gain,” the China head of a western buyout house said.
Andrew Pawley, a corporate finance director at accountancy Baker Tilly, added: “No one talks about abandoning the US if a takeover fails there.”
And foreign private equity firms have been increasing investment on the mainland, with deal values rising from US$2.7 billion in 2007 to US$5.04 billion last year, according to Dealogic.
However, Mr Dickinson cautioned these were mostly small investments in obscure companies.
“China, fundamentally, 100 per cent discourages foreigners from entering the market and there are only three conditions China will permit,” he said. “Either the company is too small for the government to care about, or it is troubled and the foreign purchaser has agreed to improve the business, or the foreign company takes a minority stake and there is a transfer of technology or expertise or access to foreign markets.
“If you don’t fit into one of these three categories you can’t do mergers or acquisitions in China and that’s the end of it.”

Enough with the death knell pronouncements. Foreign private equity investments in China is not going to die, but it will need to modify. Wise foreign private equity firms are going to need to focus on the types of deals that have a real potential to work in China. China will accept the following sorts of foreign deals:
— Foreigners are permitted to purchase small Chinese companies that the central government is not interested in managing.
— Foreigners are permitted to purchase large, state-owned enterprises that suffer from financial difficulty, provided the foreign investor agrees to restructure the purchased company.
— Foreigners are permitted to purchase non-majority interests in strong, successful Chinese companies, but only if there is some added benefit, such as transfer of technology, advanced management or access to foreign markets.
Additionally, foreign private equity firms remain free to invest in foreign companies that are in China already as a Wholly Foreign Owned Entity (WFOE) or a Joint Venture (JV) or to invest in those foreign companies planning to go into China in some way other than by purchasing a large financially viable Chinese company.
For more on China’s denial of Coke’s purchase of Huiyuan, check out the post we did earlier today on this same topic, “China Rejects Coke Deal. We Told You All This Long Ago.
UPDATE: in a post entitled, “Coke, Huiyuan and the audiences that matter,” [link no longer exists] ImageThief does a great job explaining the public relations aspect of this and any other large foreign deal in China. Its summation: “So here it is in plain language: If you’re a large foreign firm taking over a Chinese firm, prepare to be flogged in public. And prepare for it before you announce your acquisition.” True.

Print:
EmailTweetLikeLinkedIn
Photo of Dan Harris Dan Harris

Dan is a founder of Harris Bricken, an international law firm with lawyers in Los Angeles, Portland, San Francisco, Seattle, China and Spain.

He primarily represents companies doing business in emerging market countries, having spent years building and maintaining a global, professional network. 

Dan is a founder of Harris Bricken, an international law firm with lawyers in Los Angeles, Portland, San Francisco, Seattle, China and Spain.

He primarily represents companies doing business in emerging market countries, having spent years building and maintaining a global, professional network.  His work has been as varied as securing the release of two improperly held helicopters in Papua New Guinea, setting up a legal framework to move slag from Canada to Poland’s interior, overseeing hundreds of litigation and arbitration matters in Korea, helping someone avoid terrorism charges in Japan, and seizing fish product in China to collect on a debt.

He was named as one of only three Washington State Amazing Lawyers in International Law, is AV rated by Martindale-Hubbell Law Directory (its highest rating), is rated 10.0 by AVVO.com (also its highest rating), and is a recognized SuperLawyer.

Dan is a frequent writer and public speaker on doing business in Asia and constantly travels between the United States and Asia. He most commonly speaks on China law issues and is the lead writer of the award winning China Law Blog. Forbes Magazine, Fortune Magazine, the Wall Street Journal, Investors Business Daily, Business Week, The National Law Journal, The Washington Post, The ABA Journal, The Economist, Newsweek, NPR, The New York Times and Inside Counsel have all interviewed Dan regarding various aspects of his international law practice.

Dan is licensed in Washington, Illinois, and Alaska.

In tandem with the international law team at his firm, Dan focuses on setting up/registering companies overseas (via WFOEs, Rep Offices or Joint Ventures), drafting international contracts (NDAs, OEM Agreements, licensing, distribution, etc.), protecting IP (trademarks, trade secrets, copyrights and patents), and overseeing M&A transactions.